NO20043951L - 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler - Google Patents
3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midlerInfo
- Publication number
- NO20043951L NO20043951L NO20043951A NO20043951A NO20043951L NO 20043951 L NO20043951 L NO 20043951L NO 20043951 A NO20043951 A NO 20043951A NO 20043951 A NO20043951 A NO 20043951A NO 20043951 L NO20043951 L NO 20043951L
- Authority
- NO
- Norway
- Prior art keywords
- antibacterial agents
- formula
- cyclyl
- nitrogen
- membered ring
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- VWIIJDNADIEEDB-UHFFFAOYSA-N 3-methyl-1,3-oxazolidin-2-one Chemical class CN1CCOC1=O VWIIJDNADIEEDB-UHFFFAOYSA-N 0.000 title 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 title 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Forbindelser av formel (I), eller et farmasøytisk akseptabelt salt, eller en in vivo-hydrolyserbar ester derav,. hvor -N-HET er f.eks. formel (Ic) eller (If),hvor RI er f.eks. halogen eller en (l-4C)alkylgruppe som er substituert med en substi-tuent valgt fra f.eks. hydroksy, (l-4C)alkoksy, amino, cyano eller azido; Q er valgt fra f.eks. Ql, formel Qlhvor R2 og R3 er uavhengig hydrogen eller fluor; T er valgt fra en rekke grupper, f.eks. formel (TC12b). hvor m er 0,1 eller 2; er nyttige som antibakterielle midler; og fremgangsmåter for de-res fremstilling og farmasøytiske preparater som inneholder dem.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36068802P | 2002-02-28 | 2002-02-28 | |
| PCT/GB2003/000791 WO2003072576A2 (en) | 2002-02-28 | 2003-02-25 | Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20043951D0 NO20043951D0 (no) | 2004-09-21 |
| NO20043951L true NO20043951L (no) | 2004-11-11 |
Family
ID=27766238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043951A NO20043951L (no) | 2002-02-28 | 2004-09-21 | 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7199143B2 (no) |
| EP (1) | EP1480975A2 (no) |
| JP (1) | JP2005531504A (no) |
| KR (1) | KR20040086465A (no) |
| CN (1) | CN1653064A (no) |
| AR (1) | AR039559A1 (no) |
| AU (1) | AU2003209994A1 (no) |
| BR (1) | BR0308018A (no) |
| CA (1) | CA2477379A1 (no) |
| CO (1) | CO5601010A2 (no) |
| IL (1) | IL163643A0 (no) |
| IS (1) | IS7424A (no) |
| MX (1) | MXPA04008273A (no) |
| NO (1) | NO20043951L (no) |
| NZ (1) | NZ535591A (no) |
| PL (1) | PL372090A1 (no) |
| RU (1) | RU2004129278A (no) |
| TW (1) | TW200403241A (no) |
| WO (1) | WO2003072576A2 (no) |
| ZA (1) | ZA200406684B (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL160739A0 (en) | 2001-09-11 | 2004-08-31 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
| RU2004129276A (ru) * | 2002-02-28 | 2005-06-10 | Астразенека Аб (Se) | Производные 3-циклического-5-(азотсодержащего 5-членного кольцевого) метил-оксазолидинона и их применение в качестве антибактериальных средств |
| AR043050A1 (es) * | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| AU2003285509A1 (en) * | 2002-11-28 | 2004-06-18 | Astrazeneca Ab | Oxazolidinones as antibacterial agents |
| GB0306358D0 (en) | 2003-03-20 | 2003-04-23 | Astrazeneca Ab | Chemical compounds |
| WO2005042523A1 (en) * | 2003-11-03 | 2005-05-12 | Il-Dong Pharm. Co., Ltd. | A novel oxazolidinone derivative and manufacturing process thereof |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| ATE449773T1 (de) | 2005-06-29 | 2009-12-15 | Pharmacia & Upjohn Co Llc | Homomorpholinoxazolidinone als antibakterielle mittel |
| US8084477B2 (en) | 2007-10-31 | 2011-12-27 | Bristol-Myers Squibb Company | Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| KR101674146B1 (ko) | 2008-10-10 | 2016-11-08 | 머크 샤프 앤드 돔 코포레이션 | 옥사졸리디논 및 이를 포함하는 조성물을 제조하는 방법 |
| ES2734724T3 (es) | 2009-02-03 | 2019-12-11 | Merck Sharp & Dohme | Forma cristalina de dihidrogenofosfato de (R)-3-(4-(2-(2-metiltetrazol-5-il)piridin-5-il)-3-fluorofenil)-5-hidroximetiloxazolidin-2-ona |
| US8580767B2 (en) | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
| CN101792437B (zh) * | 2010-03-10 | 2012-01-25 | 天津药物研究院 | 一类三氮唑的衍生物、其制备方法和用途 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1260948A (en) * | 1984-12-05 | 1989-09-26 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
| GB9521508D0 (en) | 1995-10-20 | 1995-12-20 | Zeneca Ltd | Chemical compounds |
| GB9601666D0 (en) | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
| GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| GB9604301D0 (en) | 1996-02-29 | 1996-05-01 | Zeneca Ltd | Chemical compounds |
| GB9609919D0 (en) | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
| GB9614236D0 (en) | 1996-07-06 | 1996-09-04 | Zeneca Ltd | Chemical compounds |
| GB9614238D0 (en) | 1996-07-06 | 1996-09-04 | Zeneca Ltd | Chemical compounds |
| GB9717807D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
| GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
| AU8872198A (en) | 1997-08-29 | 1999-03-22 | Zeneca Limited | Aminometyl oxooxazolidinyl benzene derivatives |
| GB9725244D0 (en) | 1997-11-29 | 1998-01-28 | Zeneca Ltd | Chemical compounds |
| GB9812019D0 (en) | 1998-06-05 | 1998-07-29 | Zeneca Ltd | Chemical compounds |
| AU753988B2 (en) | 1998-06-05 | 2002-10-31 | Astrazeneca Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| GB9821938D0 (en) | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
| GB9928499D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical processes and intermediates |
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| CN1395569A (zh) | 2000-02-10 | 2003-02-05 | 法玛西雅厄普约翰美国公司 | 含有哌嗪酰胺取代基的噁唑二酮硫代酰胺 |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| US6277868B1 (en) * | 2000-08-31 | 2001-08-21 | Abbott Laboratories | Oxazolidinone chemotherapeutic agents |
| JP3972575B2 (ja) | 2000-11-02 | 2007-09-05 | 株式会社日立製作所 | ドアシステム |
| GB0108764D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
| GB0108793D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
| JP2004531518A (ja) | 2001-04-07 | 2004-10-14 | アストラゼネカ アクチボラグ | スルホンイミド基を含有する、抗生物質としてのオキサゾリジノン |
| GB0108794D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compound |
| GB0113297D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical Process |
| GB0113299D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical process & intermediates |
| GB0113300D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Purification process |
| GB0121490D0 (en) | 2001-09-05 | 2001-10-24 | Smithkline Beecham Plc | Ciompounds |
| IL160739A0 (en) | 2001-09-11 | 2004-08-31 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| GB2396350A (en) | 2001-10-25 | 2004-06-23 | Astrazeneca Ab | Aryl substituted oxazolidinones with antibacterial activity |
| EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
| AU2003285509A1 (en) | 2002-11-28 | 2004-06-18 | Astrazeneca Ab | Oxazolidinones as antibacterial agents |
| US20060116400A1 (en) | 2002-11-28 | 2006-06-01 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| GB0227701D0 (en) | 2002-11-28 | 2003-01-08 | Astrazeneca Ab | Chemical compounds |
| GB0229521D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| GB0229522D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| GB0229526D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| GB0229518D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| TW200500360A (en) | 2003-03-01 | 2005-01-01 | Astrazeneca Ab | Hydroxymethyl compounds |
| GB0306357D0 (en) | 2003-03-20 | 2003-04-23 | Astrazeneca Ab | Chemical compounds |
| GB0306358D0 (en) | 2003-03-20 | 2003-04-23 | Astrazeneca Ab | Chemical compounds |
-
2003
- 2003-02-25 AU AU2003209994A patent/AU2003209994A1/en not_active Abandoned
- 2003-02-25 KR KR10-2004-7013476A patent/KR20040086465A/ko not_active Withdrawn
- 2003-02-25 IL IL16364303A patent/IL163643A0/xx unknown
- 2003-02-25 BR BR0308018-8A patent/BR0308018A/pt not_active IP Right Cessation
- 2003-02-25 US US10/505,902 patent/US7199143B2/en not_active Expired - Fee Related
- 2003-02-25 EP EP03742987A patent/EP1480975A2/en not_active Withdrawn
- 2003-02-25 CN CNA038091607A patent/CN1653064A/zh active Pending
- 2003-02-25 RU RU2004129278/04A patent/RU2004129278A/ru not_active Application Discontinuation
- 2003-02-25 PL PL03372090A patent/PL372090A1/xx not_active Application Discontinuation
- 2003-02-25 MX MXPA04008273A patent/MXPA04008273A/es unknown
- 2003-02-25 NZ NZ535591A patent/NZ535591A/en unknown
- 2003-02-25 JP JP2003571282A patent/JP2005531504A/ja active Pending
- 2003-02-25 CA CA002477379A patent/CA2477379A1/en not_active Abandoned
- 2003-02-25 WO PCT/GB2003/000791 patent/WO2003072576A2/en not_active Ceased
- 2003-02-27 TW TW092104234A patent/TW200403241A/zh unknown
- 2003-02-28 AR ARP030100688A patent/AR039559A1/es unknown
-
2004
- 2004-08-23 ZA ZA200406684A patent/ZA200406684B/en unknown
- 2004-08-25 CO CO04083219A patent/CO5601010A2/es not_active Application Discontinuation
- 2004-08-26 IS IS7424A patent/IS7424A/is unknown
- 2004-09-21 NO NO20043951A patent/NO20043951L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2477379A1 (en) | 2003-09-04 |
| US20050182112A1 (en) | 2005-08-18 |
| WO2003072576A2 (en) | 2003-09-04 |
| RU2004129278A (ru) | 2005-06-10 |
| MXPA04008273A (es) | 2004-11-10 |
| EP1480975A2 (en) | 2004-12-01 |
| TW200403241A (en) | 2004-03-01 |
| IS7424A (is) | 2004-08-26 |
| AU2003209994A1 (en) | 2003-09-09 |
| BR0308018A (pt) | 2005-01-04 |
| NZ535591A (en) | 2006-07-28 |
| IL163643A0 (en) | 2005-12-18 |
| US7199143B2 (en) | 2007-04-03 |
| NO20043951D0 (no) | 2004-09-21 |
| KR20040086465A (ko) | 2004-10-08 |
| CN1653064A (zh) | 2005-08-10 |
| JP2005531504A (ja) | 2005-10-20 |
| AR039559A1 (es) | 2005-02-23 |
| ZA200406684B (en) | 2005-09-21 |
| PL372090A1 (en) | 2005-07-11 |
| CO5601010A2 (es) | 2006-01-31 |
| WO2003072576A3 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043951L (no) | 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler | |
| NO20084382L (no) | Sykloalkylaminosyrederivater og farmasoytiske sammensetninger derav | |
| MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
| NO20025091L (no) | Oksazolidinonderivater med antibiotisk aktivitet | |
| NO20085169L (no) | Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes | |
| NO20085269L (no) | 2-tioksantinderivater som fungerer som MPO-inhibitorer | |
| NO20072371L (no) | Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister | |
| TWI262917B (en) | 2-Furancarboxylic hydrazides and pharmaceutical compositions containing the same | |
| NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
| MXPA05009205A (es) | Derivados de dihidroxiisoxasol hidroximetil sustituidos utiles como agentes antibioticos. | |
| NO20074763L (no) | (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi | |
| NO20053133L (no) | Kjemiske forbindelser. | |
| YU52403A (sh) | Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže | |
| NO20072409L (no) | Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser | |
| NO20092689L (no) | Quinuclidinolderivater som muskarin reseptorantagonister | |
| NO20075617L (no) | 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| TW200626553A (en) | Novel compounds | |
| DK1425280T3 (da) | Kemiske forbindelser | |
| DE69426836D1 (de) | Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
| NO20061584L (no) | Substituerte 2-karbonylamino-6-piperidinaminopyridiner og substituerte 1-karbonylamino-3-piperidinaminobenzener som 5-HT1F agonister | |
| HUP0303204A2 (hu) | 1-Metilkarbapenem-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |